Comparison of Two Biphasic Insulin Aspart 30 Treatment Regimens in Subjects With Type 2 Diabetes Not Achieving HbA1c Treatment Targets on OADs Alone
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 245 participants.
Also called NCT01215435
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 245 participants
- Sponsor
- Registry
-
NCT01215435
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Iran
- Registry status
- Completed
Technical summary
Registry record NCT01215435. Randomized; no masking; primary purpose treatment. Start 2011-03 (registry gives no type); primary completion 2012-09 (actual). Results posted on 2013-11-25.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Comparison of Two Biphasic Insulin Aspart 30 Treatment Regimens in Subjects With Type 2 Diabetes Not Achieving HbA1c Treatment Targets on OADs Alone
- Condition
- Diabetes
- Condition
- Diabetes Mellitus, Type 2
- Intervention (Drug)
- biphasic insulin aspart 30
- Intervention (Drug)
- biphasic insulin aspart 30
- Lead sponsor
- Novo Nordisk A/S
Record details
- Record id
cardio:ct-nct01215435- Content hash
26717377899f99197de5a836f7787f5505cf792ba20fc2ee56335fb72629b802